TransMedics Group (NASDAQ:TMDX) Raised to “Strong-Buy” at Baird R W

Baird R W upgraded shares of TransMedics Group (NASDAQ:TMDX – Free Report) to a strong-buy rating in a research note released on Tuesday, Zacks.com reports. Several other research analysts also recently weighed in on the company. Stephens lifted their target price on TransMedics Group from $151.00 to $178.00 and gave the company an overweight rating […]

Leave a Reply

Your email address will not be published.

Previous post The Progressive Co. (NYSE:PGR) Insider Sells $775,320.00 in Stock
Next post Former Mille Lacs reserve deputy faces criminal sexual conduct charges